Not available
Quote | Prothena Corporation plc (NASDAQ:PRTA)
Last: | $21 |
---|---|
Change Percent: | -1.27% |
Open: | $21.61 |
Close: | $21 |
High: | $21.7006 |
Low: | $20.9475 |
Volume: | 461,582 |
Last Trade Date Time: | 04/17/2024 03:00:00 am |
News | Prothena Corporation plc (NASDAQ:PRTA)
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced the publication related to the mechanism of action, pharmacological characteristics, and clinical ut...
2024-03-20 09:00:32 ET More on Labcorp Laboratory Corporation of America Holdings (LH) Q4 2023 Earnings Call Transcript Laboratory Corporation of America Holdings 2023 Q4 - Results - Earnings Call Presentation Labcorp introduces weight loss management portfolio ...
Message Board Posts | Prothena Corporation plc (NASDAQ:PRTA)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $PRTA News Article - Prothena Reports First Quarter 2023 Financial Results and Business | whytestocks | investorshangout | 05/04/2023 8:55:53 PM |
whytestocks: $PRTA News Article - Walgreens and Prothena Partner to Increase Access and Enrollment i | whytestocks | investorshangout | 04/13/2023 3:31:04 PM |
whytestocks: $PRTA News Article - Prothena Presents New Preclinical Data Supporting Best-in-Class Pr | whytestocks | investorshangout | 03/31/2023 5:55:49 PM |
whytestocks: $PRTA News Article - Prothena Announces Achievement of $40 Million Clinical Milestone P | whytestocks | investorshangout | 11/21/2022 9:21:06 PM |
znewcar1: $PRTA 87% v10,9M c58.00 f46,9M H59.17 ML25.02 gapNgo | znewcar1 | investorshangout | 09/29/2022 2:25:02 AM |
News, Short Squeeze, Breakout and More Instantly...
Prothena Corporation plc Company Name:
PRTA Stock Symbol:
NASDAQ Market:
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced the publication related to the mechanism of action, pharmacological characteristics, and clinical ut...
2024-03-15 00:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that it has named David Ford to a newly created position of Chief People Officer, reporting to Proth...